Wouter Everaerts

On the origin of bladder sensing: Tr(i)ps in urology.

Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding.

The loss and progressive recovery of voiding after spinal cord interruption in rats is associated with simultaneous changes in autonomous contractile bladder activity.

Where is TRPV1 expressed in the bladder, do we see the real channel?

Nicotine activates the chemosensory cation channel TRPA1.

Functional characterization of transient receptor potential channels in mouse urothelial cells.

Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome.

The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil.

TRiPping down the oesophagus.

Administration of imatinib mesylate in rats impairs the neonatal development of intramuscular interstitial cells in bladder and results in altered contractile properties.

Mechanisms of transient receptor potential vanilloid 1 activation and sensitization by allyl isothiocyanate.

Transient receptor potential channel modulators as pharmacological treatments for lower urinary tract symptoms (LUTS): myth or reality?

Laparoscopy training in Belgium: results from a nationwide survey, in urology, gynecology, and general surgery residents.

Essential role of transient receptor potential M8 (TRPM8) in a model of acute cold-induced urinary urgency.

Topographies and isoforms of the progesterone receptor in female human, rat and mouse bladder.

TRPM8 antagonists to treat lower urinary tract symptoms: don't lose your cool just yet.

Tumor Volume and Clinical Failure in High-Risk Prostate Cancer Patients Treated With Radical Prostatectomy.

The stem cell growth factor receptor KIT is not expressed on interstitial cells in bladder.

Fibrous dysplasia mimicking bone metastasis on GA-PSMA PET/MRI.

The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.

Comparative study of the organisation and phenotypes of bladder interstitial cells in human, mouse and rat.

Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.

Intravesical Activation of the Cation Channel TRPV4 Improves Bladder Function in a Rat Model for Detrusor Underactivity.

Characterization of voiding function and structural bladder changes in a rat model of neurogenic underactive bladder disease.

Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy.

Functional and molecular characterisation of the bilateral pelvic nerve crush injury rat model for neurogenic detrusor underactivity.

Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.

Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.

Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.

Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification.

Current role of robotic bladder cancer surgery.

Development and External Validation of Nomograms To Predict Adverse Pathological Characteristics After Robotic Prostatectomy: Results of a Prospective, Multi-institutional, Nationwide series.

Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After Surgery.

Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer.

An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates.

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.

Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.

Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by Ga-PSMA-11 PET/CT or C-Choline PET/CT: impact of postoperative treatments.

TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides.

Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in : A Review of Secondary Prevention Guidelines.

Variation in adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy for prostate cancer: a population-based cohort study.

A novel tool to predict functional outcomes after robot-assisted radical prostatectomy and the value of additional surgery for incontinence.

Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis.

Current and emerging therapies for localized high-risk prostate cancer.

Re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.

Transient receptor potential channels in sensory mechanisms of the lower urinary tract.

Parameters predicting [F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.